Ninety One North America, Inc. Dr Reddys Laboratories LTD Transaction History

Ninety One North America, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$62.61 - $71.29 $3.48 Million - $3.97 Million	-55,627 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$51.39 - $72.41 $62,747 - $88,412	-1,221 Reduced 2.15%	55,627 $3.87 Million
Q2 2020 Aug 20, 2020	BUY	$39.55 - $54.65 $2.25 Million - $3.11 Million	56,848 New	56,848 $3.01 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $953,154 - $1.32 Million	-24,100 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$34.75 - $45.85 $837,475 - $1.1 Million	24,100 New	24,100 $972,000

264

107M

71K

22.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.22B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

Stay updated on Ninety One North America, Inc. with notifications on news.